Study on Using CYTALUX™ for Imaging Gastrointestinal Cancers During Surgery

Sponsor: Cedars-Sinai Medical Center

Sponsor score: 0

ClinicalTrials ID:NCT07124351

Provider View

This clinical trial is testing a new imaging method using CYTALUX™ to help surgeons see gastrointestinal cancers more clearly during operations. The study focuses on patients with certain types of stomach, esophageal, and appendix cancers.

Patient Parameters

Program Overview

The purpose of this study is to see if a new imaging technique using CYTALUX™ can help doctors better detect certain types of gastrointestinal cancers during surgery. This technique involves injecting a special dye that lights up cancer cells when viewed with a near-infrared camera, making it easier for surgeons to identify and remove tumors.

Eligibility Criteria

Inclusion Criteria

  • Adults aged 18 and older.
  • Have been diagnosed with or are suspected to have gastroesophageal cancer based on imaging tests, or have appendix cancer with suspected spread to the abdomen.
  • Need surgery to remove a gastroesophageal tumor or to check the extent of cancer spread in the abdomen.
  • Agree to stop taking folate or folic acid supplements 48 hours before receiving CYTALUX.
  • Willing to provide written consent to participate in the study.

Exclusion Criteria

  • Any medical condition that might make participation unsafe.
  • History of severe allergic reactions to imaging products containing indocyanine green.
  • Allergy to any ingredients in CYTALUX™.
  • Any condition that might make it difficult to follow the study procedures or attend follow-up visits.
  • Known sensitivity to fluorescent light.
  • Women who are pregnant or planning to become pregnant during the study.

Locations

FACILITYZIPCITYSTATE
Cedars-Sinai Medical Center90048Los AngelesCalifornia

Get This Program In Your Inbox

Receive detailed information about this treatment opportunity to review with your healthcare provider.